Oscar Maitas, MD
Interventional Cardiology · Seattle, WANPI 1386908531
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $14,304 of the $22,153 with a category attached, or 64.6%. 34 manufacturers reported payments, led by Abbott at 26.6% of the total.
Across 408 payments — averaging $54.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Edwards Lifesciences$4K
- Biotronik Inc.$2K
- Medtronic$1K
- Johnson & Johnson$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$879
- plus $7K from 28 others
What the payments were for
- Travel & lodging$7,36833%
- Food & beverage$14,30465%
- Education$4812%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 63 | $5,889 |
| Edwards Lifesciences | 38 | $3,647 |
| Biotronik Inc. | 22 | $2,383 |
| Medtronic | 17 | $1,423 |
| Johnson & Johnson | 66 | $1,233 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $879 |
| AstraZeneca | 32 | $853 |
| Amgen | 20 | $836 |
| Boston Scientific | 9 | $656 |
| Shockwave Medical, Inc | 7 | $613 |
| Pfizer | 25 | $571 |
| Novartis | 18 | $534 |
| Abiomed | 16 | $521 |
| Novo Nordisk | 3 | $258 |
| Astellas Pharma US Inc | 5 | $255 |
| Esperion Therapeutics, Inc. | 9 | $249 |
| E.r. Squibb & Sons, L.L.C. | 17 | $222 |
| Alnylam Pharmaceuticals Inc. | 4 | $197 |
| Impulse Dynamics (USA) Inc. | 1 | $149 |
| United Therapeutics Corporation | 1 | $120 |
| Lantheus Medical Imaging, Inc. | 1 | $113 |
| Livanova USA, Inc. | 3 | $94 |
| Penumbra, Inc. | 2 | $79 |
| Chiesi USA, Inc. | 1 | $72 |
| Actelion Pharmaceuticals US, Inc. | 2 | $64 |
| Eko Health, Inc. | 1 | $60 |
| Baxter Healthcare | 1 | $38 |
| Inari Medical, Inc. | 2 | $29 |
| Lexicon Pharmaceuticals, Inc. | 1 | $28 |
| Kestra Medical Technology Services, Inc. | 1 | $23 |
| Biosense Webster, Inc. | 1 | $20 |
| Angiodynamics, Inc. | 1 | $16 |
| Cook Medical LLC | 1 | $15 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EnSite Precision Cardiac Mapping System$1,900
- Acticor$1,272
- Edora$1,272
- Rivacor$1,272
- Solia$1,049
- BioMonitor$1,049
- TRICLIP$997
- COREVALVE EVOLUT R$812
- ENSITE PRECISION$725
- Repatha$557
- SAPIEN 3 Ultra RESILIA$536
- Edwards SAPIEN 3 Transcatheter Heart Valve$498
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$492
- GALLANT$334
- OPTIMIZER$299
- FARXIGA$225
- Plexa$223
- Sentus$223
- LifeVest$215
- ONYX FRONTIER$164
How this compares
$22,153 in reported general payments places this provider in the 80th percentile of 125 interventional cardiology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 23 | $316 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Seattle
- William LombardiSeattle$902K
- Kathleen KearneySeattle$448K
- Danny DvirSeattle$374K
- James McCabeSeattle$289K
- Christopher BrownSeattle$266K
- Lorenzo AzzaliniSeattle$233K
- Sidakpal PanaichSeattle$214K
- Christine ChungSeattle$210K
- Sameer GafoorSeattle$80K
- Ravi HiraSeattle$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.